Get started
BIOVICA INTERNATIONAL AB BTA BBIOVICA INTERNATIONAL AB BTA BBIOVICA INTERNATIONAL AB BTA B

BIOVICA INTERNATIONAL AB BTA B

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

BIOVIC_BTA_B chart


Full chart

BIOVIC_BTA_B upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪149.93 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.878 SEK
Net income (FY)
‪−87.62 M‬ SEK
Revenue (FY)
‪8.62 M‬ SEK
Shares float
‪199.03 M‬
Beta (1Y)
2.02

Employees


Employees (FY)
26
Change (1Y)
−11 −29.73%
Revenue / Employee (1Y)
‪331.50 K‬ SEK
Net income / Employee (1Y)
‪−3.37 M‬ SEK

About BIOVICA INTERNATIONAL AB SER. B


Sector
Health Technology
Industry
Biotechnology
CEO
Anders Rylander
Website
biovica.com
Headquarters
Uppsala
Founded
2008
ISIN
SE0025198617
FIGI
BBG01VHCMDD8
Biovica International AB is engages in the development and commercialization of novel blood-based biomarker assays to improve the monitoring of modern cancer therapies. It offers DiviTum assay, which is intended to monitor and predict treatment response in cancer patients. The company was founded in 2009 and is headquartered in Uppsala, Sweden.

Check out other big names from the same industry as BIOVIC_BTA_B.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BIOVIC_BTA_B news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BIOVIC_BTA_B is 0.640 SEK — it has decreased by −1.84% in the past 24 hours. Watch BIOVICA INTERNATIONAL AB BTA B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange BIOVICA INTERNATIONAL AB BTA B stocks are traded under the ticker BIOVIC_BTA_B.
BIOVIC_BTA_B stock has fallen by −91.73% compared to the previous week, the month change is a −91.73% fall, over the last year BIOVICA INTERNATIONAL AB BTA B has showed a −91.73% decrease.
BIOVIC_BTA_B reached its all-time high on Dec 2, 2022 with the price of 10.000 SEK, and its all-time low was 7.300 SEK and was reached on Dec 9, 2022. View more price dynamics on BIOVIC_BTA_B chart.
See other stocks reaching their highest and lowest prices.
BIOVIC_BTA_B stock is 5.16% volatile and has beta coefficient of 2.02. Track BIOVICA INTERNATIONAL AB BTA B stock price on the chart and check out the list of the most volatile stocks — is BIOVICA INTERNATIONAL AB BTA B there?
Yes, you can track BIOVICA INTERNATIONAL AB BTA B financials in yearly and quarterly reports right on TradingView.
BIOVICA INTERNATIONAL AB BTA B is going to release the next earnings report on Sep 11, 2025. Keep track of upcoming events with our Earnings Calendar.
BIOVIC_BTA_B earnings for the last quarter are −0.19 SEK per share, whereas the estimation was −0.29 SEK resulting in a 32.26% surprise. The estimated earnings for the next quarter are −0.10 SEK per share. See more details about BIOVICA INTERNATIONAL AB BTA B earnings.
BIOVICA INTERNATIONAL AB BTA B revenue for the last quarter amounts to ‪2.00 M‬ SEK, despite the estimated figure of ‪4.00 M‬ SEK. In the next quarter, revenue is expected to reach ‪2.68 M‬ SEK.
BIOVIC_BTA_B net income for the last quarter is ‪−20.77 M‬ SEK, while the quarter before that showed ‪−22.82 M‬ SEK of net income which accounts for 8.98% change. Track more BIOVICA INTERNATIONAL AB BTA B financial stats to get the full picture.
No, BIOVIC_BTA_B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 9, 2025, the company has 26 employees. See our rating of the largest employees — is BIOVICA INTERNATIONAL AB BTA B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOVICA INTERNATIONAL AB BTA B EBITDA is ‪−77.55 M‬ SEK, and current EBITDA margin is −950.04%. See more stats in BIOVICA INTERNATIONAL AB BTA B financial statements.
Like other stocks, BIOVIC_BTA_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOVICA INTERNATIONAL AB BTA B stock right from TradingView charts — choose your broker and connect to your account.